How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Dan Gartland writes Sports Illustrated’s flagship daily newsletter, SI:AM, and is the host of the “Stadium Wonders” video series. He joined the SI staff in 2014, having previously been published on ...

While the tech giant has the means to fight in court, ongoing legal battles could temper a long-term recovery in its shares.

Dan Neil is the author of the “Rumble Seat” column which runs Saturdays in The Wall Street Journal. Previously, Mr. Neil was the auto columnist for the Los Angeles Times from 2003 to 2010. He also ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...